Cargando…
The effect of Co-Q10 on allergic rhinitis and allergic asthma
BACKGROUND: Allergic asthma is an inflammatory disease resulting from continued or intermittent allergen exposure, and allergic rhinitis can be trigger of asthma. The main mechanism of these disease is allergic reaction and immune response dysregulation. Co-Q10 is an enzyme cofactor in mitochondria...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980733/ https://www.ncbi.nlm.nih.gov/pubmed/33743807 http://dx.doi.org/10.1186/s13223-021-00534-5 |
_version_ | 1783667483660517376 |
---|---|
author | Du, Qixue Meng, Wei Athari, Seyyed Shamsadin Wang, Renzhong |
author_facet | Du, Qixue Meng, Wei Athari, Seyyed Shamsadin Wang, Renzhong |
author_sort | Du, Qixue |
collection | PubMed |
description | BACKGROUND: Allergic asthma is an inflammatory disease resulting from continued or intermittent allergen exposure, and allergic rhinitis can be trigger of asthma. The main mechanism of these disease is allergic reaction and immune response dysregulation. Co-Q10 is an enzyme cofactor in mitochondria can control asthma and allergic rhinitis symptoms. In the present study, we determined that the CoQ10-induced anti-allergic effects were mediated by up-regulation of Nrf2. METHODS: Animal models of allergic rhinitis and allergic asthma were produced and treated with Co-Q10, Co-Q10 and O-3, Co-Q10 and Mg-S. Bronchoalveolar lavage fluid was collected from animal models, and IL-4, 5, 13, INF-y, Eicosanoids, IgE, EPO, and histamine production were measured. Also, COX-2, CCL24, CCL11, Nrf2, Eotaxin, Cytb, COX1 and ND1 genes expressions and histopathology were studied. BALf's cells were collected by tracheostomy and used in slide producing by cytospine. Cytokines, Eicosanoids, IgE, EPO, and histamine were measured by ELISA method. Gene expression was done by Real-time PCR. RESULTS: Co-Q10 with two supplementation (Mg-S and O-3) modulate MRC, BALf eosinophils, eosinophilic inflammation related genes (eotaxin, CCL11 and CCL24), peribronchial and perivascular inflammation, EPO, type 2 cytokines (IL-4, 5 and 13), IgE, histamine, Cyc-LT and LTB4 as main allergic bio-factors. Importantly, Co-Q10 treatment increased Nrf2 expression and Nrf2 induced antioxidant genes, glutathione redox and inhibited inflammation, oxidative stress injury, Th2 cytokines production and attenuated allergic inflammatory responses. CONCLUSION: Nrf2 is activated in response to allergen, induces resistance against the rhinitis and asthma development and plays an essential role in broncho-protection. Co-Q10 increases the Nrf2 expression and the Nrf2 over-expression has strong effect in control of type2 cytokines, allergic mediators and inflammatory factors that lead to harnessing of allergy and asthma. GRAPHIC ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-7980733 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79807332021-03-22 The effect of Co-Q10 on allergic rhinitis and allergic asthma Du, Qixue Meng, Wei Athari, Seyyed Shamsadin Wang, Renzhong Allergy Asthma Clin Immunol Research BACKGROUND: Allergic asthma is an inflammatory disease resulting from continued or intermittent allergen exposure, and allergic rhinitis can be trigger of asthma. The main mechanism of these disease is allergic reaction and immune response dysregulation. Co-Q10 is an enzyme cofactor in mitochondria can control asthma and allergic rhinitis symptoms. In the present study, we determined that the CoQ10-induced anti-allergic effects were mediated by up-regulation of Nrf2. METHODS: Animal models of allergic rhinitis and allergic asthma were produced and treated with Co-Q10, Co-Q10 and O-3, Co-Q10 and Mg-S. Bronchoalveolar lavage fluid was collected from animal models, and IL-4, 5, 13, INF-y, Eicosanoids, IgE, EPO, and histamine production were measured. Also, COX-2, CCL24, CCL11, Nrf2, Eotaxin, Cytb, COX1 and ND1 genes expressions and histopathology were studied. BALf's cells were collected by tracheostomy and used in slide producing by cytospine. Cytokines, Eicosanoids, IgE, EPO, and histamine were measured by ELISA method. Gene expression was done by Real-time PCR. RESULTS: Co-Q10 with two supplementation (Mg-S and O-3) modulate MRC, BALf eosinophils, eosinophilic inflammation related genes (eotaxin, CCL11 and CCL24), peribronchial and perivascular inflammation, EPO, type 2 cytokines (IL-4, 5 and 13), IgE, histamine, Cyc-LT and LTB4 as main allergic bio-factors. Importantly, Co-Q10 treatment increased Nrf2 expression and Nrf2 induced antioxidant genes, glutathione redox and inhibited inflammation, oxidative stress injury, Th2 cytokines production and attenuated allergic inflammatory responses. CONCLUSION: Nrf2 is activated in response to allergen, induces resistance against the rhinitis and asthma development and plays an essential role in broncho-protection. Co-Q10 increases the Nrf2 expression and the Nrf2 over-expression has strong effect in control of type2 cytokines, allergic mediators and inflammatory factors that lead to harnessing of allergy and asthma. GRAPHIC ABSTRACT: [Image: see text] BioMed Central 2021-03-20 /pmc/articles/PMC7980733/ /pubmed/33743807 http://dx.doi.org/10.1186/s13223-021-00534-5 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Du, Qixue Meng, Wei Athari, Seyyed Shamsadin Wang, Renzhong The effect of Co-Q10 on allergic rhinitis and allergic asthma |
title | The effect of Co-Q10 on allergic rhinitis and allergic asthma |
title_full | The effect of Co-Q10 on allergic rhinitis and allergic asthma |
title_fullStr | The effect of Co-Q10 on allergic rhinitis and allergic asthma |
title_full_unstemmed | The effect of Co-Q10 on allergic rhinitis and allergic asthma |
title_short | The effect of Co-Q10 on allergic rhinitis and allergic asthma |
title_sort | effect of co-q10 on allergic rhinitis and allergic asthma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980733/ https://www.ncbi.nlm.nih.gov/pubmed/33743807 http://dx.doi.org/10.1186/s13223-021-00534-5 |
work_keys_str_mv | AT duqixue theeffectofcoq10onallergicrhinitisandallergicasthma AT mengwei theeffectofcoq10onallergicrhinitisandallergicasthma AT athariseyyedshamsadin theeffectofcoq10onallergicrhinitisandallergicasthma AT wangrenzhong theeffectofcoq10onallergicrhinitisandallergicasthma AT duqixue effectofcoq10onallergicrhinitisandallergicasthma AT mengwei effectofcoq10onallergicrhinitisandallergicasthma AT athariseyyedshamsadin effectofcoq10onallergicrhinitisandallergicasthma AT wangrenzhong effectofcoq10onallergicrhinitisandallergicasthma |